Controversial view of a genetically altered mouse model of focal retinal degeneration

Bioengineered

Volumn 4, Issue 3, 2013, Pages

  Chu, Xi K ^a   Wang, Yujuan ^a   Ardeljan, Daniel ^a   Tuo, Jingsheng ^a   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Age related macular degeneration; Animal model; Ccl2; Cx3cr1; rd8; TSG 6

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; LIPOFUSCIN; MEMBRANE COFACTOR PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

APOPTOSIS; ARTICLE; CELL INTERACTION; IMMUNOPATHOLOGY; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PHOTORECEPTOR; PIGMENT EPITHELIUM; RETINA DEGENERATION; RETINA DYSTROPHY; TRANSGENIC MOUSE; AGE-RELATED MACULAR DEGENERATION; ANIMAL; ANIMAL MODEL; C57BL MOUSE; CCL2; CX3CR1; DISEASE MODEL; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MOUSE; RD8; TSG-6;

AGE-RELATED MACULAR DEGENERATION; ANIMAL MODEL; CCL2; CX3CR1; RD8; TSG-6;

ANIMALS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RETINAL DEGENERATION;

EID: 84877696645     PISSN: 19491018     EISSN: 19491026     Source Type: Journal    
DOI: 10.4161/bioe.22949     Document Type: Article

References (34)

1. Tuo J, Cao X, Shen D, Wang Y, Zhang J, Oh JY, et al. Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model. J Neuroinflammation 2012; 9:59; PMID:22452753; http://dx.doi.org/10.1186/1742-2094-9-59.
2. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, Kuziel WA, et al. An animal model of agerelated macular degeneration in senescent Ccl-2-or Ccr-2-deficient mice. Nat Med 2003; 9:1390-7; PMID:14566334; http://dx.doi.org/10.1038/nm950.
3. Combadière C, Feumi C, Raoul W, Keller N, Rodéro M, Pézard A, et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 2007; 117:2920-8; PMID:17909628; http://dx.doi.org/10.1172/JCI31692.
4. Chen M, Forrester JV, Xu H. Dysregulation in retinal para-inflammation and age-related retinal degeneration in CCL2 or CCR2 deficient mice. PLoS One 2011; 6:e22818; PMID:21850237; http:// dx.doi.org/10.1371/journal.pone.0022818.
5. Raoul W, Feumi C, Keller N, Lavalette S, Houssier M, Behar-Cohen F, et al. Lipid-bloated subretinal microglial cells are at the origin of drusen appearance in CX3CR1-deficient mice. Ophthalmic Res 2008; 40:115-9; PMID:18421223; http://dx.doi. org/10.1159/000119860.
6. Tuo J, Bojanowski CM, Zhou M, Shen D, Ross RJ, Rosenberg KI, et al. Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human agerelated macular degeneration. Invest Ophthalmol Vis Sci 2007; 48:3827-36; PMID:17652758; http:// dx.doi.org/10.1167/iovs.07-0051.
7. Ramkumar HL, Zhang J, Chan CC. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD). Prog Retin Eye Res 2010; 29:169-90; PMID:20206286; http://dx.doi. org/10.1016/j.preteyeres.2010.02.002.
8. Mattapallil MJ, Wawrousek EF, Chan CC, Zhao H, Roychoudhury J, Ferguson TA, et al. The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci 2012; 53:2921-7; PMID:22447858; http://dx.doi.org/10.1167/iovs.12-9662.
9. Luhmann UF, Lange CA, Robbie S, Munro PM, Cowing JA, Armer HE, et al. Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signalling. PLoS One 2012; 7:e35551; PMID:22545116; http://dx.doi.org/10.1371/journal. pone.0035551.
10. den Hollander AI, Heckenlively JR, van den Born LI, de Kok YJ, van der Velde-Visser SD, Kellner U, et al. Leber congenital amaurosis and retinitis pigmentosa with Coats-like exudative vasculopathy are associated with mutations in the crumbs homologue 1 (CRB1) gene. Am J Hum Genet 2001; 69:198-203; PMID:11389483; http://dx.doi. org/10.1086/321263.
11. Mehalow AK, Kameya S, Smith RS, Hawes NL, Denegre JM, Young JA, et al. CRB1 is essential for external limiting membrane integrity and photoreceptor morphogenesis in the mammalian retina. Hum Mol Genet 2003; 12:2179-89; PMID:12915475; http://dx.doi.org/10.1093/hmg/ddg232.
12. van de Pavert SA, Sanz AS, Aartsen WM, Vos RM, Versteeg I, Beck SC, et al. Crb1 is a determinant of retinal apical Müller glia cell features. Glia 2007; 55:1486-97; PMID:17705196; http://dx.doi. org/10.1002/glia.20561.
13. Shen D, Cao X, Zhao L, Tuo J, Wong WT, Chan CC. Naloxone ameliorates retinal lesions in Ccl2/ Cx3cr1 double-deficient mice via modulation of microglia. Invest Ophthalmol Vis Sci 2011; 52:2897-904; PMID:21245403; http://dx.doi.org/10.1167/ iovs.10-6114.
14. Chan CC, Ross RJ, Shen D, Ding X, Majumdar Z, Bojanowski CM, et al. Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res 2008; 40:124-8; PMID:18421225; http://dx.doi.org/10.1159/000119862.
15. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) 1988; 2:552-77; PMID:2476333; http:// dx.doi.org/10.1038/eye.1988.106.
16. Mettu PS, Wielgus AR, Ong SS, Cousins SW. Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration. Mol Aspects Med 2012; 33:376-98; PMID:22575354; http://dx.doi.org/10.1016/j. mam.2012.04.006.
17. Sparrow JR, Nakanishi K, Parish CA. The lipofuscin fluorophore A2E mediates blue lightinduced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 2000; 41:1981-9; PMID:10845625.
18. Zhou J, Jang YP, Kim SR, Sparrow JR. Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci U S A 2006; 103:16182-7; PMID:17060630; http://dx.doi.org/10.1073/ pnas.0604255103.
19. Zhou J, Kim SR, Westlund BS, Sparrow JR. Complement activation by bisretinoid constituents of RPE lipofuscin. Invest Ophthalmol Vis Sci 2009; 50:1392-9; PMID:19029031; http://dx.doi. org/10.1167/iovs.08-2868.
20. Algvere PV, Marshall J, Seregard S. Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand 2006; 84:4-15; PMID:16445433; http://dx.doi.org/10.1111/j.1600-0420.2005.00627.x.
21. Ross RJ, Zhou M, Shen D, Fariss RN, Ding X, Bojanowski CM, et al. Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration. Exp Eye Res 2008; 86:675-83; PMID:18308304; http://dx.doi.org/10.1016/j.exer.2008.01.014.
22. Tuo J, Ross RJ, Herzlich AA, Shen D, Ding X, Zhou M, et al. A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am J Pathol 2009; 175:799-807; PMID:19608872; http://dx.doi.org/10.2353/ajpath.2009.090089.
23. Tuo J, Pang JJ, Cao X, Shen D, Zhang J, Scaria A, et al. AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2(-/-)/Cx3cr1(-/-) mice. Neurobiol Aging 2012; 33:433, e1-10; PMID:21397984; http:// dx.doi.org/10.1016/j.neurobiolaging.2011.01.009.
24. Eisener-Dorman AF, Lawrence DA, Bolivar VJ. Cautionary insights on knockout mouse studies: the gene or not the gene? Brain Behav Immun 2009; 23:318-24; PMID:18822367; http://dx.doi. org/10.1016/j.bbi.2008.09.001.
25. Cousins SW, Espinosa-Heidmann DG, Alexandridou A, Sall J, Dubovy S, Csaky K. The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. Exp Eye Res 2002; 75:543-53; PMID:12457866; http://dx.doi.org/10.1006/exer.2002.2047.
26. Dithmar S, Sharara NA, Curcio CA, Le NA, Zhang Y, Brown S, et al. Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch Ophthalmol 2001; 119:1643-9; PMID:11709015; http://dx.doi.org/10.1001/ archopht.119.11.1643.
27. Shen D, Wen R, Tuo J, Bojanowski CM, Chan CC. Exacerbation of retinal degeneration and choroidal neovascularization induced by subretinal injection of Matrigel in CCL2/MCP-1-deficient mice. Ophthalmic Res 2006; 38:71-3; PMID:16352919; http://dx.doi.org/10.1159/000090266.
28. Cao J, Zhao L, Li Y, Liu Y, Xiao W, Song Y, et al. A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap. Invest Ophthalmol Vis Sci 2010; 51:6009-17; PMID:20538989; http://dx.doi.org/10.1167/ iovs.09-4956.
29. Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjanik NL, et al. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 1998; 153:1641-6; PMID:9811357; http://dx.doi. org/10.1016/S0002-9440(10)65753-7.
30. Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 2000; 157:135-44; PMID:10880384; http://dx.doi.org/10.1016/S0002-9440(10)64525-7.
31. Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L, et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 2008; 14:194-8; PMID:18223656; http://dx.doi.org/10.1038/nm1709.
32. Hollyfield JG, Perez VL, Salomon RG. A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration. Mol Neurobiol 2010; 41:290-8; PMID:20221855; http://dx.doi.org/10.1007/ s12035-010-8110-z.
33. Xu H, Chen M, Forrester JV. Para-inflammation in the aging retina. Prog Retin Eye Res 2009; 28:348-68; PMID:19560552; http://dx.doi.org/10.1016/j. preteyeres.2009.06.001.
34. Patel M, Chan CC. Immunopathological aspects of age-related macular degeneration. Semin Immunopathol 2008; 30:97-110; PMID:18299834; http://dx.doi.org/10.1007/s00281-008-0112-9.